Healthtech Startups

Imaginable Solutions makes Guided Hands, an assistive device that helps people with limited fine motor skills write, draw, paint, and use technology by translating shoulder movements into guided hand motions. It serves individuals with limited hand dexterity in the assistive/medical device category.

1 investor

1 investor

Imaging Associates is a radiology practice in Australia providing diagnostic imaging services through clinics in Melbourne, Victoria, and Wagga Wagga, NSW, staffed by senior radiologists focused on patient care and using advanced medical imaging technology.

1 investor

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments. It has operated for over 130 years and serves patients and healthcare needs globally.

1 investor

IMAI develops 3D histology technology for early and accurate diagnosis of cancer to improve therapeutic outcomes and patient care in oncology.

1 investor

Imanyco designs inclusive products and solutions for individuals with disabilities, aiming to enhance daily living through thoughtful innovation. The company focuses on breaking down barriers and creating accessibility-centered offerings that promote dignity and independence.

1 investor

imaware operates a white-label biomarker testing platform that enables healthcare partners to offer personalized health data and testing services to consumers across 50 U.S. states. The platform integrates with existing healthcare systems and provides HIPAA-compliant results, analytics, and support for virtual care.

1 investor

Imbed Biosciences is a medical device company that develops SAMatrix, an ultra-thin, fully synthetic bioresorbable wound matrix that integrates antimicrobial silver and non-opioid pain agents (lidocaine) for treating chronic and acute wounds such as ulcers, surgical, traumatic, and burn wounds. Its product portfolio includes Surgaflex, Pelashield, and Microlyte, along with PainGuard variants.

1 investor

Imbiba is a UK and Ireland-based investment firm that provides capital up to £15m or €15m to high-growth companies in education, healthcare, lifestyle, and technology sectors. The firm is led by serial entrepreneurs and experienced investors who support portfolio companies from early growth through scaling.

1 investor

IMBRUVICA is a prescription cancer medication (available as capsules, tablets, and oral suspension) used to treat B-cell malignancies such as CLL/SLL and Waldenström's macroglobulinemia, as well as chronic graft-versus-host disease in adults and children. It is marketed by AbbVie, and the page provides patient dosing instructions, safety warnings, and side-effect information.

1 investor

Amplicare provides software and pharmacy solutions for retail, community, and outpatient pharmacies to manage workflows and patient engagement. The platform serves multiple pharmacy business models including PSAOs, GPOs, independent pharmacies, and pharmacy partners with tools for medication management and patient adherence.

1 investor

iMediSync develops AI and machine learning-based diagnostic platforms for neuropsychiatric and brain disorders, including tools for early dementia detection and Parkinson's disease classification. The company serves healthcare providers and institutions with FDA-approved software medical devices and wearable technology.

1 investor

An enterprise that develops and commercializes biomedical materials and biopharmaceutical products, including Class III and Class II medical devices, dermal fillers, facial threads, and proteins/peptides for medical aesthetics, dermatology, surgery, metabolic disease, and professional skincare.

1 investor

Imerman Angels is a nonprofit organization that facilitates fundraising through athletic events and sports participation to support cancer patients, survivors, and caregivers. The organization connects individuals facing cancer with trained mentors who provide one-on-one emotional and practical support.

1 investor

Imhotex is a biotech company focused on drug development, managed by experienced professionals in therapeutic discovery and clinical advancement. The company appears to focus on translating scientific research into novel drug candidates.

1 investor

IMIDomics develops a patient data-driven clinical discovery platform to identify drug targets for immune-mediated inflammatory diseases (IMIDs), building on 17+ years of research and data from over 17,000 IMID patients. The company combines deep immunology expertise with computational analysis to discover first-in-class therapeutics for diseases like rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus.

1 investor

Immersify is a mobile-first digital learning platform offering clinician-authored lessons, quizzes, flashcards, simulations, and AR/3D content mapped to dental and healthcare curricula and accreditation standards (US CODA and UK GDC). It serves universities, students, and healthcare corporates for education, product training, and sales enablement, and provides education analytics for institutions.</parameter> <parameter name="sector_codes">["edtech", "digital_health", "ai_ml"]

1 investor

Immersiv Health operates a network of infusion therapy centers serving patients with chronic conditions across Colorado and Texas. The company provides outpatient infusion treatments as an alternative to hospital-based care, alongside administrative support and provider services.

1 investor

ImmPro provides top-down proteomics analytical services for biopharmaceutical development, using single-particle protein analysis to characterize proteins and proteoforms. Its offerings support gene therapy vector characterization, biomarker discovery, and disease-specific assays for areas such as neurodegeneration, oncology, and cardiometabolic disease.

1 investor

ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.

1 investor

IMMUNETHEP is a biotechnology company, spun off from the University of Porto, developing immunology-based technology originating from the Laboratory of Immunology of ICBAS. It conducts R&D from its facilities at Biocant Park in Cantanhede, Portugal.

1 investor

Immunicom is a biotech company developing immunotherapies based on its Immunopheresis platform, a blood-filtering device that works external to the body to treat cancer and inflammatory, cardiovascular, renal, and autoimmune diseases. Its initial focus is immuno-oncology, with CE Mark approval in Europe for advanced triple-negative breast cancer and multiple ongoing clinical trials.

1 investor

Immunique is a science-based biotech company developing cell therapies that restore balance in the immune system to treat disease and support long-term patient recovery. Its research focuses on immune cell function and is aimed at extending healthy lifespan through clinical- and data-driven treatment strategies.

1 investor

A searchable database of peer-reviewed evidence on the benefits of immunization, designed for child health advocates, researchers, and policymakers. Created by the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health.

1 investor